{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:59:04Z","timestamp":1790852344719,"version":"4.1.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Neogen\u00ae Corporation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The validation of a semi-quantitative method for the rapid screening of whole blood and urine specimens using the Neogen\u00ae Gabapentin kit is presented. Decision points were validated at 1000\u2009ng\/mL for whole blood and urine. The validation design was based on ANSI\/ASB 036 and internal laboratory requirements. Experiments included the evaluation of sensitivity, precision, specificity, carryover, hook effect, drift, ruggedness\/robustness, interference, and an authentic case sample comparison. The experimental limit of detection (LOD) for gabapentin was determined to be at least 500\u2009ng\/mL in whole blood and urine. Excellent precision was demonstrated when the assay was evaluated using the mean of three replicates from five separate runs (n\u2009=\u200915) at the decision point and at concentration levels \u221250% and +100% of the decision point. The assay was reliably able to detect gabapentin without interference from matrix components or other substances routinely detected in authentic case samples with the exception of levamisole in urine if present at unusually high concentrations. Urine samples with 50\u2009\u00b5g\/mL or more of levamisole yielded a false positive screening result. Other case sample results were comparable to those obtained with liquid chromatography tandem high-resolution mass spectrometry or liquid chromatography tandem mass spectrometry for blood and urine, respectively. The Neogen\u00ae Gabapentin kit exhibited minimal cross-reactivity for pregabalin and demonstrated excellent precision and appropriate sensitivity in both whole blood and urine, making it an efficient and reliable method to screen for gabapentin.<\/jats:p>","DOI":"10.1093\/jat\/bkag077","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:39:29Z","timestamp":1788867569000},"source":"Crossref","is-referenced-by-count":0,"title":["Validation of the Neogen\u00ae enzyme-linked immunosorbent assay gabapentin kit for blood and urine"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6758-6753","authenticated-orcid":false,"given":"Nicholas B","family":"Tiscione","sequence":"first","affiliation":[{"name":"Palm Beach County Sheriff\u2019s Office Toxicology Unit, , 3228 Gun Club Road , West Palm Beach, FL 33406,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe E","family":"Rosenberger","sequence":"additional","affiliation":[{"name":"Palm Beach County Sheriff\u2019s Office Toxicology Unit, , 3228 Gun Club Road , West Palm Beach, FL 33406,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonela","family":"Placencia","sequence":"additional","affiliation":[{"name":"Palm Beach County Sheriff\u2019s Office Toxicology Unit, , 3228 Gun Club Road , West Palm Beach, FL 33406,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward X","family":"Zumaeta","sequence":"additional","affiliation":[{"name":"Palm Beach County Sheriff\u2019s Office Toxicology Unit, , 3228 Gun Club Road , West Palm Beach, FL 33406,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"2026100106370877000_bkag077-B1","volume-title":"In: StatPearls [Internet].","author":"Yasaei","year":"2024"},{"key":"2026100106370877000_bkag077-B2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1535-7597.2005.05210.x","article-title":"Not another gabapentin mechanism!","volume":"5","author":"Sills","year":"2005","journal-title":"Epilepsy Curr"},{"key":"2026100106370877000_bkag077-B3","doi-asserted-by":"publisher","first-page":"e00205","DOI":"10.1002\/prp2.205","article-title":"Mechanisms of the gabapentinoids and alpha 2 delta-1 calcium channel subunit in neuropathic pain","volume":"4","author":"Patel","year":"2016","journal-title":"Pharmacol Res Perspect"},{"key":"2026100106370877000_bkag077-B4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4140\/TCP.n.2019.490","article-title":"Gabapentin: change is in the wind","volume":"34","author":"McPherson","year":"2019","journal-title":"Sr Care Pharm"},{"key":"2026100106370877000_bkag077-B5","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1002\/jcph.1833","article-title":"Gabapentinoid pharmacology in the context of emerging misuse liability","volume":"61 Suppl 2","author":"Evoy","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"2026100106370877000_bkag077-B6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/jat\/33.8.545","article-title":"Prevalence of gabapentin in impaired driving cases in Washington State in 2003-2007","volume":"33","author":"Peterson","year":"2009","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B7","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/1556-4029.15500","article-title":"Gabapentin in drugged driving investigations","volume":"69","author":"Bierly","year":"2024","journal-title":"J Forensic Sci"},{"key":"2026100106370877000_bkag077-B8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/jat\/bkaf029","article-title":"North America laboratory survey data for drug testing in drug-impaired driving and traffic fatality investigations","volume":"49","author":"D\u2019Orazio","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkaf085","article-title":"Recommendations for toxicological investigation of drug-impaired driving and motor vehicle fatalities-2025 update","volume":"50","author":"D\u2019Orazio","year":"2026","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B10","author":"ARK gabapentin assay package insert"},{"key":"2026100106370877000_bkag077-B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/jat\/17.3.133","article-title":"Analysis of whole blood for drugs of abuse using EMIT d.a.u. reagents and a Monarch 1000 chemistry analyzer","volume":"17","author":"Diosi","year":"1993","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/jat\/19.6.333","article-title":"Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood","volume":"19","author":"Huang","year":"1995","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B13"},{"key":"2026100106370877000_bkag077-B14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/jat\/bkz010","article-title":"Validation of the Neogen ELISA benzodiazepine kit using clonazepam as the target molecule for blood and urine","volume":"43","author":"Behnke","year":"2019","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jat\/bkx005","article-title":"Validation of the Neogen(R) fentanyl ELISA kit for blood and urine","volume":"41","author":"Tiscione","year":"2017","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B16","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1093\/jat\/bkx095","article-title":"The validation of ELISA screening according to SWGTOX recommendations","volume":"42","author":"Tiscione","year":"2018","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B17","author":"Neogen gabapentin ELISA kit instructions","year":"2025"},{"key":"2026100106370877000_bkag077-B18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/jat\/bky060","article-title":"Validation and cross-reactivity data for fentanyl analogs with the Immunalysis fentanyl ELISA","volume":"43","author":"Guerrieri","year":"2019","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B19","author":"TX blood LC-HRMS screen"},{"key":"2026100106370877000_bkag077-B20","author":"TX blood LC-HRMS quant","year":"2020"},{"key":"2026100106370877000_bkag077-B21","author":"TX urine hydrolysis by LC-MSMS","year":"2026"},{"key":"2026100106370877000_bkag077-B22","author":"Tiscione","year":"2025"},{"key":"2026100106370877000_bkag077-B23","author":"TX scope of testing"},{"key":"2026100106370877000_bkag077-B24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.23907\/2017.039","article-title":"Levamisole: a high performance cutting agent","volume":"7","author":"Solomon","year":"2017","journal-title":"Acad Forensic Pathol"},{"key":"2026100106370877000_bkag077-B25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/anatox\/35.3.176","article-title":"Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry","volume":"35","author":"Lynch","year":"2011","journal-title":"J Anal Toxicol"},{"key":"2026100106370877000_bkag077-B26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2298\/vsp141105022b","article-title":"Fatal cocaine intoxication in a body packer","volume":"73","author":"Brajkovic","year":"2016","journal-title":"Vojnosanit Pregl"},{"key":"2026100106370877000_bkag077-B27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.forsciint.2016.01.005","article-title":"Levamisole-adulterated cocaine: two fatal case reports and evaluation of possible cocaine toxicity potentiation","volume":"265","author":"Indorato","year":"2016","journal-title":"Forensic Sci Int"},{"key":"2026100106370877000_bkag077-B28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.forsciint.2016.01.015","article-title":"Levamisole adulterated cocaine and pulmonary vasculitis: presentation of two lethal cases and brief literature review","volume":"265","author":"Karch","year":"2016","journal-title":"Forensic Sci Int"},{"key":"2026100106370877000_bkag077-B29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/jat\/bkz046","article-title":"Characterization of an amphetamine interference from gabapentin in an LC-HRMS method","volume":"44","author":"Munoz-Munoz","year":"2020","journal-title":"J Anal Toxicol"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag077\/71014535\/bkag077.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/9\/bkag077\/71014535\/bkag077.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/9\/bkag077\/71014535\/bkag077.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:37:15Z","timestamp":1790851035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag077\/8789770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag077","relation":{},"ISSN":["1945-2403"],"issn-type":[{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"bkag077"}}